Thromboembolic Complications and Prophylaxis Patterns in Colorectal Surgery
- PMID: 26060977
- PMCID: PMC4545402
- DOI: 10.1001/jamasurg.2015.1057
Thromboembolic Complications and Prophylaxis Patterns in Colorectal Surgery
Abstract
Importance: Venous thromboembolism (VTE) is an important complication of colorectal surgery, but its incidence is unclear in the era of VTE prophylaxis.
Objective: To describe the incidence of and risk factors associated with thromboembolic complications and contemporary VTE prophylaxis patterns following colorectal surgery.
Design, setting, and participants: Prospective data from the Washington State Surgical Care and Outcomes Assessment Program (SCOAP) linked to a statewide hospital discharge database. At 52 Washington State SCOAP hospitals, participants included consecutive patients undergoing colorectal surgery between January 1, 2006, and December 31, 2011.
Main outcomes and measures: Venous thromboembolism complications in-hospital and up to 90 days after surgery.
Results: Among 16,120 patients (mean age, 61.4 years; 54.5% female), the use of perioperative and in-hospital VTE chemoprophylaxis increased significantly from 31.6% to 86.4% and from 59.6% to 91.4%, respectively, by 2011 (P < .001 for trend for both). Overall, 10.6% (1399 of 13,230) were discharged on a chemoprophylaxis regimen. The incidence of VTE was 2.2% (360 of 16,120). Patients undergoing abdominal operations had higher rates of 90-day VTE compared with patients having pelvic operations (2.5% [246 of 9702] vs 1.8% [114 of 6413], P = .001). Those having an operation for cancer had a similar incidence of 90-day VTE compared with those having an operation for nonmalignant processes (2.1% [128 of 6213] vs 2.3% [232 of 9902], P = .24). On adjusted analysis, older age, nonelective surgery, history of VTE, and operations for inflammatory disease were associated with increased risk of 90-day VTE (P < .05 for all). There was no significant decrease in VTE over time.
Conclusions and relevance: Venous thromboembolism rates are low and largely unchanged despite increases in perioperative and postoperative prophylaxis. These data should be considered in developing future guidelines.
Conflict of interest statement
Figures
Comment in
-
More Evidence That the Use of Venous Thromboembolism Rates as Hospital Quality Measures May Be Off the Mark.JAMA Surg. 2015 Aug;150(8):721. doi: 10.1001/jamasurg.2015.1065. JAMA Surg. 2015. PMID: 26061867 No abstract available.
-
Misclassification of Acceptable Venous Thromboembolism Prophylaxis Leading to Flawed Inferences and Recommendations Regarding Prevention Efforts.JAMA Surg. 2016 Feb;151(2):197-8. doi: 10.1001/jamasurg.2015.3411. JAMA Surg. 2016. PMID: 26501553 No abstract available.
-
Misclassification of Acceptable Venous Thromboembolism Prophylaxis Leading to Flawed Inferences and Recommendations Regarding Prevention Efforts--Reply.JAMA Surg. 2016 Feb;151(2):198-9. doi: 10.1001/jamasurg.2015.3428. JAMA Surg. 2016. PMID: 26501764 Free PMC article. No abstract available.
References
-
- Geerts W. Prevention of venous thromboembolism: a key patient safety priority. J Thromb Haemost. 2009;7(suppl 1):1–8. - PubMed
-
- Geerts WH, Bergqvist D, Pineo GF, et al. American College of Chest Physicians. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) Chest. 2008;133(6) suppl:381S–453S. - PubMed
-
- Guyatt GH, Akl EA, Crowther M, Gutterman DD, Schuünemann HJ American College of Chest Physicians Antithrombotic Therapy and Prevention of Thrombosis Panel. . Executive summary: Antithrombotic Therapy and Prevention of Thrombosis 9th ed American College of Chest Physicians Evidence-Based Clinical Practice [published corrections appear in Chest 2012;141(4):1129 and 2012 142 6 1698 ] Chest. 2012;141(2 suppl):7S–47S. - PMC - PubMed
-
- Lyman GH, Khorana AA, Kuderer NM, et al. American Society of Clinical Oncology Clinical Practice. . Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2013;31(17):2189–2204. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
